Generic drugs can go through a bioequivalence (BE) study to determine if they have the same safety and efficacy of the innovator (brand-name) drugs, the Food and Drug Administration (FDA) said yesterday, as it clarified four common misconceptions about generic drugs.
When a brand-name drug’s patent expires, other companies can start selling generic versions of the drug, FDA Medicinal Product Division deputy head Lin Yi-chu (林意筑) said.
Of the 23,472 FDA-issued drug permit licenses that are currently valid, 17,510 are for generic drugs, or about 74 percent, Lin said.
Photo: CNA
A drug company that applies for a drug permit license for a generic drug with the same active ingredient, dosage form (the physical form in which a drug is administered) and dosage as a brand-name drug, needs to go through a BE study to prove that its safety and efficacy are the same as the brand-name drug, she said.
However, many people have misconceptions about generic drugs, including that they have not undergone clinical trials, their efficacy is only about 80 percent of the brand-name drugs, attending a BE study is a means to earn money, or that anyone can become a BE study participant, FDA Deputy Director-General Wang Der-yuan (王德原) said.
When an oral drug is administered, it is mainly absorbed in the intestines. In a BE study, blood tests are then taken to determine if the same amount of the active ingredient is released into the blood stream at the same rate as the brand-name drug, Lin said.
The mean values of the pharmacokinetic parameters of both medicinal products are compared and the 90 percent confidence intervals (CIs) are calculated. If the CIs are contained between 80 percent and 125 percent, the BE is demonstrated, she said, adding that this is an internationally agreed upon standard.
A BE study is a type of clinical research. The brand-name drug has already been proven safe and effective, so if the generic drug is proven to be bioequivalent to its brand-name counterpart, its safety and efficacy are also proven, Taiwan Association of Institutional Review Boards chairperson Chang Fung-wei (張芳維) said.
Participants of BE studies do not earn money, but the study organizers usually provide transportation, meals and nutrition fees, he said.
After a drug company gets an institutional review board approval for its BE study, it would send an informed consent form to participants. Those participants are required to strictly follow the instructions detailed in the form, including limits on eating certain foods or taking other drugs, Chang said.
The entire study process must also follow the good clinical practice guidelines to ensure the reliability of clinical trial results and the protection of patients, he added.
In addition, BE study participants must be healthy adults, and there are usually eligibility criteria, such as age, gender and body mass index (BMI) range among others, as well as the exclusion of people with chronic or acute illnesses, pregnant or breast-feeding women, and those taking certain prescription drugs, Chang said.
Actor Darren Wang (王大陸) was questioned by prosecutors for allegedly orchestrating an attack on a taxi driver after he was allegedly driven on a longer than necessary route in a car he disliked. The questioning at the New Taipei City District Prosecutors’ Office was ongoing as of press time last night. Police have recommended charges of attempted murder. The legally embattled actor — known for his role in the coming-of-age film Our Times (我的少女時代) — is under a separate investigation for allegedly using fake medical documents to evade mandatory military service. According to local media reports, police said Wang earlier last year ordered a
CAUTION: Based on intelligence from the nation’s security agencies, MOFA has cautioned Taiwanese travelers about heightened safety risks in China-friendly countries The Ministry of Foreign Affairs (MOFA) yesterday urged Taiwanese to be aware of their safety when traveling abroad, especially in countries that are friendly to China. China in June last year issued 22 guidelines that allow its courts to try in absentia and sentence to death so-called “diehard” Taiwanese independence activists, even though Chinese courts have no jurisdiction in Taiwan. Late last month, a senior Chinese official gave closed-door instructions to state security units to implement the guidelines in countries friendly to China, a government memo and a senior Taiwan security official said, based on information gathered by Taiwan’s intelligence agency. The
Taiwan Semiconductor Manufacturing Co (TSMC), the world’s largest contract chipmaker, said yesterday that it is looking to hire 8,000 people this year, at a time when the tech giant is expanding production capacity to maintain its lead over competitors. To attract talent, TSMC would launch a large-scale recruitment campaign on campuses across Taiwan, where a newly recruited engineer with a master’s degree could expect to receive an average salary of NT$2.2 million (US$60,912), which is much higher than the 2023 national average of NT$709,000 for those in the same category, according to government statistics. TSMC, which accounted for more than 60 percent
President William Lai (賴清德) should protect Taiwan Semiconductor Manufacturing Co (TSMC), and stop supporting domestic strife and discord, former president Ma Ying-jeou (馬英九) wrote on Facebook yesterday. US President Donald Trump and TSMC on Monday jointly announced that the company would invest an additional US$100 billion over the next few years to expand its semiconductor manufacturing operations in the US. The TSMC plans have promoted concern in Taiwan that it would effectively lead to the chipmaking giant becoming Americanized. The Lai administration lacks tangible policies to address concerns that Taiwan might follow in Ukraine’s footsteps, Ma wrote. Instead, it seems to think it could
RSS